Table 2 Efficacy outcomes of visual analogue total nasal symptom scores

 Nasal congestion

Baseline

8.18 ± 1.25

8.50 ± 1.11

0.29

4th week

6.54 ± 1.35

6.27 ± 1.07

0.3

8th week

4.9 ± 1.23

4.21 ± 1.07

0.02

P value

< 0.0001

< 0.0001

 Rhinorrhea

Baseline

7.32 ± 1.51

7.32 ± 1.72

0.99

4th week

5.23 ± 1.39

6.14 ± 1.63

0.02

8th week

3.28 ± 1.28

4.93 ± 1.54

< 0.0001

P value

< 0.0001

< 0.0001

 Sneezing

Baseline

9.06 ± 0.78

9.27 ± 0.69

0.26

4th week

6.42 ± 0.93

8.05 ± 0.71

< 0.0001

8th week

4.05 ± 0.62

6.82 ± 0.78

< 0.0001

P value

< 0.0001

< 0.0001

 Itching

Baseline

8.69 ± 1.24

8.08 ± 1.41

0.07

4th week

6.03 ± 1.19

6.76 ± 1.47

0.03

8th week

3.83 ± 1.33

5.32 ± 1.48

< 0.0001

P value

< 0.0001

< 0.0001